Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...
Creating data products is a good way to accelerate delivery, reuse data assets, reduce risks, and manage costs. Standardized ...
CRISPR Therapeutics wins FDA pediatric approval for Casgevy, boosting market potential and pipeline upside despite slow uptake. Click here to read more.
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials ...
PC gaming has undergone several graphical quantum leaps in its rich history, thanks to 3dfx, Nvidia, AMD, and even IBM. Here ...
When you send a prompt to an AI provider, something happens to that text before the response arrives. Most providers store it ...
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results